NCT03263312

Brief Summary

This is a single center prospective longitudinal exercise training study and will enroll approximately 50 Fontan patients and 20 controls of a similar age, gender, BMI and physical activity level between the ages of 10-40 years. Participants will undergo an MRI of the Fontan circulation. This will include imaging of the heart, lung and liver. This will include specific imaging for tissue characterization and assessment of myocardial fibrosis, liver fibrosis and disproportionate pulmonary blood flow. The investigators will then draw blood (approximately 10 ml) for assessment of serum biomarkers and circulating microRNAs of interest. The participants will undergo exercise testing and will then start a 3-6 month long cardiac rehabilitation program. After the 3-6 month study period the participants will return back for a follow up and repeat all the testing completed at enrollement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 28, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

September 5, 2021

Status Verified

September 1, 2021

Enrollment Period

7.4 years

First QC Date

August 24, 2017

Last Update Submit

September 2, 2021

Conditions

Keywords

myocardial fibrosisexercise trainingFontan

Outcome Measures

Primary Outcomes (1)

  • Peak VO2

    Improvement in Peak VO2 with 6 months of exercise training

    6 months

Study Arms (1)

Fontan Patients

EXPERIMENTAL

All Fontan patients included in this study will be part of an exercise intervention 2-6 times/week for 3-6 months.

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Exercise training all patients enrolled.

Also known as: Training
Fontan Patients

Eligibility Criteria

Age10 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Presence of a congenital heart defect that leads to single ventricle physiology
  • Previously performed TCPA surgery
  • Current age 10 years to 40 years
  • Informed consent

You may not qualify if:

  • History of exercise intolerance (peak VO2\<12ml/kg/min)
  • Unstable arrhythmia at the time of screening
  • Listed or being evaluated for heart transplantation
  • Pregnancy or breast feeding
  • Patient with pacemaker, AV block other than 1st degree block, sick sinus syndrome or other arrhythmia that may influence ability to perform exercise test or magnetic resonance imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children'sMCD

Irving, Texas, 75063, United States

Location

Related Publications (1)

  • Bano M, Hussain T, Samels MR, Butts RJ, Kirk R, Levine BD. Cardiovascular remodelling in response to exercise training in patients after the Fontan procedure: a pilot study. Cardiol Young. 2024 Mar;34(3):604-613. doi: 10.1017/S1047951123003153. Epub 2023 Sep 4.

MeSH Terms

Conditions

Univentricular Heart

Interventions

Exercise

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 24, 2017

First Posted

August 28, 2017

Study Start

January 1, 2018

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

September 5, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations